First-in-Man, Dose-escalation Trial of c-Met Kinase Inhibitor EMD 1204831 in Subjects With Advanced Solid Tumors

NCT01110083 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

38

Enrollment

INDUSTRY

Sponsor class

Stopped Please see "Purpose" statement below.

Conditions

Solid Tumors

Interventions

DRUG: EMD 1204831

Sponsor

EMD Serono